Clinical Trial Update: 13-valent Pneumococcal Conjugate Vaccine Study in Adults and Children in India [Phase 4]

View source ↗

Summary

Phase 4 trial in India evaluating the prevention of pneumonia and invasive pneumococcal disease caused by serotypes included in the 13-valent pneumococcal conju…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Pneumococcal Disease
• Pneumonia

Drugs mentioned

• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Prevention of Pneumonia and Invasive Disease Caused by the Serotypes in 13vPnC | Phase 4 | Status: COMPLETED | Results posted: 2016-07-01